Journal Article Epublish
PubMed: 42055412 DOI: 10.6004/jnccn.2025.7250
CGE26-144: Impact of OPRM1 Genetic Variants on Adverse Reactions and Opioid Switching in Lung Cancer Patients.
J Natl Compr Canc Netw 24(3.5)
Authors: José Augusto Sakae Defende, Bruna Évelyn Briotto Lima, Julia Tiemi Siguemoto, Giovana Fernanda Santos Fidelis, Nadine de Godoy Torso, Yasmim Gabriele Matos, Isabella Amaral Muniz, Mariana Vieira Morau, Mauricio Wesley Perroud, Carolina Dagli-Hernandez, Eder de Carvalho Pincinato, Patricia Moriel
Affiliations
- 1School of Pharmaceutical Sciences, University of Campinas (UNICAMP), Campinas, SP, Brazil.
- 2Faculty of Medical Sciences, University of Campinas (UNICAMP), Campinas, SP, Brazil.
- 3School of Pharmaceutical Sciences (FCF), University of São Paulo (USP), São Paulo, SP, Brazil.
MeSH
Lung, Neoplasms, Lung Neoplasms